17:29 EDT Hoth Therapeutics (HOTH) up 52% at $0.78 per share after HT-VA data
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOTH:
- Hoth Therapeutics Completes Registered Direct Offering Financing
- Hoth Therapeutics announces $2M registered direct offering
- Hoth Therapeutics reports results from ongoing HT-001 program
- Hoth Therapeutics announces issuance of Chinese patent
- Hoth Therapeutics’ HT-001 shows positive PK, safety and clinical activity